DAVY VIEW

Trading in the latter months of the year to March 31st was as expected at Oxford Instruments (OXIG). FYMar24 adjusted EBITA is expected to be in line with consensus (£79.9m) and it enters FY25 with a strong order book. We continue to forecast strong organic growth in the coming year and look forward to the strategy update on June 11th and the July 10th site visit to the newly expanded Bristol facility. The shares look good value and we reiterate our ‘Outperform’ rating.